The mean TBS at the lumbar spine was 1.38±0.13. The TBS showed a negative correlation with disease duration and inflammatory markers, and a positive correlation with BMD at the lumbar spine, femoral neck, and total hip. It also showed a negative correlation with sacroiliitis grade. BMD at the lumbar spine positively correlated with SASSS, whereas TBS showed a negative correlation. A significant decrease in TBS values was observed in patients with spinal radiographic progression (p=0.001). Multivariate analysis showed that ESR and sacroiliitis were independently associated with TBS (p=0.006 and <0.001, respectively). Ten patients had morphometric vertebral fractures. The mean TBS was lower in patients with vertebral fracture than in age-matched patients without fracture (p=0.028). Conclusions: The TBS in young male patients with AS is associated with the ESR and severity of sacroiliitis. The TBS may be useful as a tool for assessing osteoporosis in AS.
FRI0449 ANALYSIS OF THE CANADIAN ADALIMUMAB POST-MARKETING OBSERVATIONAL EPIDEMIOLOGICAL STUDY ASSESSING EFFECTIVENESS IN ANKYLOSING SPONDYLITIS (COMPLETE-AS): ASSOCIATION BETWEEN BASELINE EXTRA ARTICULAR MANIFESTATIONS AND PATIENT-REPORTED OUTCOMES
Results: A total of 569 patients were included in the current analysis. Mean (SD) age and duration of disease was 43.3 (13.4) and 5.9 (9.8) years, respectively. The majority of patients enrolled were male (57.1%), Caucasian (86.1%), HLA B27 + (67.0%), and RF -(93.7%). The most common baseline EAM reported was enthesitis (15.3%), followed by psoriasis (13.0%), inflammatory bowel disease (IBD; 9.1%), and uveitis (3.2%). EAM combination 1 (EAM1: all EAMs) and EAM combination 2 (EAM2: excluding psoriasis), was reported by 33.2%, and 23.7% of patients, respectfully. Regression analysis adjusting for baseline BASDAI and BASFI, found enthesitis, EAM1, and EAM2 to be significant negative predictors of SF-36 PCS scores (p<0.05). Individual EMAs were not found to impact PROs, except for uveitis, found to be a negative predictor of SF-36 PCS scores for which a statistical trend was identified (p<0.15). No association between EAMs and SF-36 MCS, BD-II or WLQ scores were found. Conclusions: In a Canadian routine clinical care setting, a substantial proportion of AS patients requiring a change in treatment report EAMs. Patients with EAMs were found to have significant reduction in baseline QoL specifically related to physical functioning.
